Patient preference trial comparing capecitabine and S-1 in metastatic breast cancer patients.
Phase 2
- Conditions
- metastatic breast carcinoma
- Registration Number
- JPRN-UMIN000013045
- Lead Sponsor
- Japan Breast Cancer Research Network
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
ECOG performance status is more than 3
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method patient preference
- Secondary Outcome Measures
Name Time Method PFS, OS, address quality of life (EORTC-30), and anxiety and depression (HADS)